1 / 44

Management of Acute Severe Colitis

Management of Acute Severe Colitis. Dr Jayne Eaden Consultant Gastroenterologist , UHCW. Symptoms. Bloody diarrhoea (urgency & tenesmus) Abdominal pain Weight loss Obstructive symptoms Abdominal mass (esp RIF). Warning Signs. Fever > 37.8 o C Dehydration

alda
Télécharger la présentation

Management of Acute Severe Colitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Management of Acute Severe Colitis Dr Jayne Eaden Consultant Gastroenterologist, UHCW

  2. Symptoms • Bloody diarrhoea (urgency & tenesmus) • Abdominal pain • Weight loss • Obstructive symptoms • Abdominal mass (esp RIF)

  3. Warning Signs • Fever > 37.8 oC • Dehydration • Tachycardia (P>90), Hypotension • Abdominal pain and tenderness (beware toxic dilatation and perforation) • Patients can look well if been on steroids - beware

  4. Other Signs • Mouth ulcers • Perianal disease • Erythema nodosum • Pyoderma gangrenosum • Eye disease • Arthropathy (large joints, asymmetrical and non-deforming)

  5. Truelove & Witts Criteria Defines severe Ulcerative Colitis Bowels open > 6 times per 24 hours Plus any one or more of the systemic manifestations • Haemoglobin < 10.5 • ESR > 30 • Pulse rate > 90 • Temperature > 37.5

  6. Differential Diagnoses • Bacterial infection • C. diff, Campylobacter, Salmonella, Shigella, E. coli 0157 • Viral infection if immuno-compromised (CMV) • Amoeba especially if travel history • Crohn’s colitis and ischaemia • Diverticulitis can occasionally mimic

  7. Investigations on Admission Bloods • FBC • ESR & CRP • U&E, creat • LFT (albumin) • Blood cultures (if temp > 38°) • Glucose • (Mg+ and Cholesterol)

  8. Investigations on Admission • Stool Culture and Microscopy • C. Diff (3 separate samples) • AXR: look for stool-free colon (indicates extent involved); severe disease indicated by mucosal oedema (thickened wall), mucosal islands, dilated small bowel loops, colonic dilatation (diameter > 6cm) • Inform the surgeons on call if the colon is dilated

  9. Colectomy more likely if: -Mucosal islands present -Dilated small bowel loops

  10. Investigations on Admission • Arrange a sigmoidoscopy and rectal biopsy. DO NOT prescribe bowel prep • should be done within 24 - 48 hours of admission • Avoid colonoscopy and barium enema in patients with acute, severe colitis

  11. Daily Investigations • Bloods • FBC • U&E, creat (particularly watch the potassium) • LFT • CRP (a vital prognostic guide) • AXR for severe extensive colitis (any of fever, tachycardia, tenderness, dilatation on initial films) – in absence of these criteria less frequent AXR is OK • Results must be reviewed the same day (esp potassium) particularly if abdominal X-ray is requested.

  12. Extra Investigations • In appropriate patients, send Amoebic Fluorescent Antibody test • Check CMV titre if patient is not responding after 3 days (EDTA sample)

  13. Daily Monitoring • Temperature and pulse • Stool chart • Frequency • Colour / blood content • Estimate of volume (record even if only passed blood or mucus) • Abdo examination findings • tenderness, bowel sounds • Note increasing pulse / temp / abdominal pain or tenderness may indicate deterioration or frank perforation and requires appropriate urgent investigation and d/w SpR / consultant.

  14. Management • Rehydrate with IV fluids • Correct electrolyte imbalance (in particular potassium) • Nutrition : Low residue diet (IV fluids if vomiting) • Inform colorectal surgeons & IBD nurse

  15. Management • Corticosteroids: Hydrocortisone 100mg QDS IV until remission achieved. May use Predsol/Predfoam PR once or twice per day (mainly for distal disease) • Antibiotics (if febrile / toxic dilatation) • Severely anaemic patients (Hb < 9g / dl) should be considered for transfusion • DVT prophylaxis e.g enoxaparin 40mg od

  16. Management • Look for and treat proximal constipation • If stop 5-ASA, restart on discharge DO NOT • Use opiates / codeine phosphate/ loperamide (may precipitate paralytic ileus, megacolon and proximal constipation) • Use anti-cholinergics

  17. Travis Criteria After three days of intravenous hydrocortisone, the presence of either • Stool frequency > 8 times per 24 hours or • Stool frequency > 3 times + CRP > 45 gives an 85% likelihood of requiring colectomy on the same admission

  18. The Management of Acute Severe UC: options for rescue....... If no improvement by day 3 make plans for day 5! • Surgery or • Cyclosporine or • Infliximab • MUST be discussed with a Consultant Gastroenterologist

  19. Indications for colectomy • Toxic dilatation with failure to improve clinically / radiologically within 24 hrs • Perforation • Uncontrolled lower GI haemorrhage • Failure to respond after 3 days IV steroids • Deterioration at any stage

  20. Acute severe UC:the role of cyclosporine • Only use if stool cultures negative • Toxic drug – safety is paramount • IV hydrocortisone is continued • Check Mg+ and ensure cholesterol >3 • Be aware of side effects (seizures) • Care in elderly / hypertensive / impaired renal function

  21. Acute severe UC:the role of cyclosporine What dose? • 2mg/kg as IV infusion in 500mls glucose over 2-6 hrs • Monitor levels (100-200mcg/l trough) • Levels monitored at UHCW Mon-Fri • Rapid steroid wean once clinical response • If responded switch to oral after 3-5 days: • 5mg/kg/day in 2 divided doses

  22. Acute severe UC:the role of cyclosporine – long term outcome • Clinical experience from Oxford • 76 pts from 1996-2003 followed 2.9 yrs • 54 received 4mg/kg, 22 oral 5mg/kg • 74% entered clinical remission and left hospital • BUT 65% relapse at 1 yr, 90% at 3 yrs • 58% of those came to colectomy at 7 yrs

  23. Acute severe UC:the role of cyclosporine – exit strategy • Azathioprine naive vs refractory........ • Ideally check TPMT levels on admission • Commence Azathioprine at discharge • Wean off Cyclosporine after 6-8 weeks • Septrin 960mg alt days – prophylaxis against opportunistic infection • Early follow up to check remission and bloods

  24. Acute severe UC:the role of infliximab – safety issues • Possible risk of lymphoma & malignancy • Increased if pt on other immunosuppressants • Infectious complications (VZV, candida) • Serious in 3% • TB reactivation (PPD & CXR required prior to treatment) • Interactions tacrolimus/ live vaccines

  25. Acute severe UC:the role of infliximab – safety issues • Contraindications: • Sepsis • Significantly raised LFTs (x3), • Hypersensitivity to infliximab • Active TB • Pregnancy } avoid for 6 months after • Breast Feeding } stopping treatment • Cautions: • Previous TB • Hepatic Impairment • Renal Impairment • Heart Failure • Mouse allergies • > 14 weeks since last infusion

  26. Infliximab for chronic active UC:can we predict who will respond? • Serum albumin <30g/l: 67% vs 23% colectomy OR 6.86 (1.03-45.6) p=0.05 (Lees et al APT 2007) • No effect of smoking status, age, stool frequency or disease extent

  27. Management of acute severe UC:summary of evidence • Acute severe UC requires specialist care within an experienced MDT • Confirm diagnosis and exclude infection • Non responders should be identified early and salvage therapy considered • Controlled trials of cyclosporine vs infliximab are awaited

  28. Management of acute severe UC:a multi disciplinary model Physicians Surgeons The Patient Combined approach Nurses Dieticians Pharmacists Radiologists Pathologists

More Related